SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001447028-20-000073
Filing Date
2020-06-24
Accepted
2020-06-24 16:22:10
Documents
6
Effectiveness Date
2020-06-24

Document Format Files

Seq Description Document Type Size
1 S-8 a2020-sx8xregistrationstat.htm S-8 142283
2 EXHIBIT 5.1 a2020-sx8xex51.htm EX-5.1 11042
3 EXHIBIT 23.1 a2020-sx8xex231.htm EX-23.1 3328
4 EXHIBIT 23.2 a2020-sx8xex232.htm EX-23.2 2924
5 farrispage1.jpg GRAPHIC 2617
6 farrispage2.jpg GRAPHIC 2046
  Complete submission text file 0001447028-20-000073.txt   167400
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239407 | Film No.: 20985755
SIC: 2834 Pharmaceutical Preparations